Voyager Technologies, Inc.
VOYG
$23.98
+17.95%
Voyager Technologies, Inc. is a defense and space technology company operating across three divisions: Defense and National Security (pioneering communications, guidance/navigation/control, signals intelligence and defense systems), Space Solutions (space infrastructure, science systems and mission services from LEO to deep space), and Starlab, a commercial space station intended to succeed the ISS and sustain a permanent human presence in orbit. As a recently public (June 2025 NYSE listing) pure-play space and defense platform with roughly 800 employees, Voyager is positioning itself as an integrated prime contractor spanning national-security payloads, civil space infrastructure, and commercial orbital destinations — a differentiated niche relative to single-segment lunar or launch competitors. The current investor narrative is dominated by the completed Astrobotic acquisition and a $298 million NASA contract award that together transform Voyager from a space-station specialist into a key lunar contractor, fueling a violent August 2026 rally followed by a sharp autumn give-back as investors weigh explosive top-line growth against widening losses, rising debt, dilution risk, and the capital intensity of Starlab. Coverage debates now center on whether the company can convert its growing government backlog into sustainable margins before its cash burn forces further external financing.…
VOYG
Voyager Technologies, Inc.
$23.98
Related headlines
Investment Opinion: Should I buy VOYG Today?
Rating: Hold (speculative, high-risk). The core thesis is that Voyager's 124.1% YoY revenue growth ($88.72M in Q3 2026 vs. $39.59M), a $298M NASA award, and the Astrobotic acquisition have built genuine multi-year backlog, but a -$291.66M TTM free cash flow burn and a -62.8% net margin mean the equity is a financing-dependent story whose outcome hinges on operating leverage that has not yet appeared. The roughly 5-to-1 bullish analyst skew (BTIG, KeyBanc, TD Cowen, Citigroup, Wedbush, Jefferies vs. one Morgan Stanley Underweight) and consensus forward EPS of $4.39 anchor a constructive long-term view, but with no average price target in the data, upside cannot be quantified and the ratings are stale relative to the -42.70% three-month collapse.
Supporting evidence is mixed but tilts toward patient accumulation rather than aggressive buying. The PS multiple has compressed from 92.1x in Q1'25 to 9.17x today — the bottom of its post-IPO band and at the low end of 10–20x space-tech comps, though still a steep premium to A&D primes at 1.5–2.5x sales. Revenue accelerated sequentially from $35.25M (Q1'26) to $52.75M (Q2'26) to $88.72M (Q3'26), and gross margin recovered from -16.4% in Q1'26 to 11.5% in Q3'26. Against that, gross profit of $10.23M is dwarfed by $64.2M of SG&A plus R&D, interest expense jumped to $2.70M from $0.20M, and debt-to-equity sits at 1.22x versus 0.018x a year ago — the balance sheet, not the income statement, is the swing factor.
Three risks could invalidate the thesis: a financing-window closure forcing dilutive equity issuance (Q3 burn of $57.89M against $553.6M cash implies roughly 2–3 quarters of runway before another raise), failure of gross margin to hold double digits as contract mix shifts, and a single-analyst downgrade wave given thin five-analyst coverage on a $1.5B market cap. This Hold would upgrade to Buy if gross margin holds above 15% for two consecutive quarters while quarterly FCF burn narrows below $30M, or if the stock reclaims the $30.25 October shelf on volume; it would downgrade to Sell on a break below the $20.33 52-week low or a dilutive raise at a depressed price. Verdict: fairly valued to modestly undervalued versus its own history (9.2x PS vs. 92.1x peak) but expensive versus defense peers — a speculative position, not a core holding.
Sign up to view all
VOYG 12-Month Price Forecast
Voyager is a high-beta, pre-profit space and defense platform where the fundamental trajectory, not the analyst ratings, will decide the outcome. The bull case is real — 124.1% revenue growth, a $298M NASA award, and a PS multiple de-rated to 9.17x from 92.1x — but the bear case holds the stronger near-term evidence: losses widening in absolute terms, -$291.66M TTM free cash flow, and leverage up to 1.22x. The stock's -42.70% three-month decline against SPY's -4.91% and -60.73% max drawdown reflect a market that has stopped paying for growth without profitability, and the +17.95% reversal off the $20.33 low on 2.26M shares is a single session, not a trend change. I would upgrade to bullish on two consecutive quarters of gross margin above 15% with FCF burn below $30M, or a decisive reclaim of $30.25; I would downgrade to bearish on a break below $20.33 or any dilutive raise at a depressed price.
Wall Street consensus
Five analysts cover Voyager with a consensus that leans bullish but is fraying at the edges: the distribution shows three Buy/Overweight/Outperform ratings (BTIG Buy, KeyBanc Overweight, TD Cowen Buy, Citigroup Buy, Wedbush Outperform, Jefferies Buy) against one notable bear (Morgan Stanley Underweight, downgraded from Equal Weight on 2026-07-15). Consensus forward EPS estimates average $4.39 (range $3.42–$4.77) on average revenue of $3.06 billion, implying the Street expects a dramatic swing to profitability that the current -$0.91 quarterly EPS does not yet support; a precise average price target is not available in the provided data, so implied upside cannot be calculated, but the ratings skew (roughly 5 bullish vs. 1 bearish) signals net positive sentiment despite the stock's -42.70% three-month collapse.
The signal strength is mixed: most firms have reiterated rather than changed ratings recently (BTIG and KeyBanc reaffirmed in early November, TD Cowen and Citigroup held Buy through the autumn), suggesting analysts are anchoring on the long-term NASA/Astrobotic story rather than reacting to the price decline — a pattern that can precede either a sharp re-rating or a wave of capitulation downgrades. The bull case (high targets) assumes successful Astrobotic integration, Starlab contract wins, and operating leverage driving the $4.39 forward EPS; the bear case (Morgan Stanley's Underweight) prices in continued cash burn, dilution, and margin compression. The wide dispersion between the $3.42 low and $4.77 high EPS estimates — a 39% spread — signals genuine uncertainty about the earnings trajectory, and with only five analysts covering a $1.5 billion market-cap recent IPO, coverage is thin enough that single-firm actions can move the stock disproportionately and price discovery remains inefficient.
Drowning in data?
Find the real signal!
Bulls vs Bears: VOYG Investment Factors
The bear case currently holds the stronger near-term evidence: losses are widening in absolute terms (-$55.68M net in Q3 versus -$16.27M a year earlier), free cash flow is -$291.66 million TTM, and leverage has jumped to 1.22x debt-to-equity, all while the stock has lost 42.70% in three months and badly lagged the S&P. The bull case rests on genuinely impressive top-line momentum — 124.1% YoY revenue growth, a $298 million NASA award, and a PS multiple compressed to 9.17x from 92.1x — plus a 5-to-1 bullish analyst skew that has held through the decline. The single most important tension is whether the 124% growth is durable contracted demand or acquisition-aided optics: if Voyager converts its government backlog into gross margins above the mid-teens and narrows the cash burn, the de-rated multiple offers real upside; if losses persist and another capital raise arrives, the 9.2x PS is a warning rather than a bargain. Until operating leverage materializes, this is a high-beta, headline-driven name where the fundamental trajectory, not the analyst ratings, will decide the outcome.
Bullish
- Revenue accelerating at triple-digit rate: Q3 2026 revenue of $88.72 million grew 124.1% year-over-year from $39.59 million and 68.2% sequentially from Q2's $52.75 million, a clear acceleration from $35.25M in Q1'26. The $298 million NASA award plus the Astrobotic acquisition give this growth multi-year contracted visibility rather than one-quarter optics.
- PS multiple compressed to post-IPO low: The price-to-sales ratio has collapsed from 92.1x in Q1'25 and 43.9x a year ago to 9.17x today, placing the stock at the bottom of its own post-IPO valuation band. At 9.2x sales the market is no longer pricing euphoria, and the multiple sits at the low end of high-growth space/defense-tech comps that have historically commanded 10–20x revenue.
- Analyst consensus still leans bullish: Roughly five of six covering firms carry Buy/Overweight/Outperform ratings (BTIG, KeyBanc, TD Cowen, Citigroup, Wedbush, Jefferies) against a single Morgan Stanley Underweight, and most reiterated through the autumn decline. Consensus forward EPS of $4.39 (range $3.42–$4.77) on average revenue of $3.06 billion implies the Street expects a dramatic swing to profitability.
- Liquidity buffer funds the build-out: Voyager held $553.6 million in cash at quarter-end, up from $373.4M via $343.7M of net financing inflows, with a 4.37x current ratio and 2.88x quick ratio. That runway covers the $57.89 million Q3 free cash flow burn for several quarters while Starlab and lunar programs mature.
Bearish
- Losses widening, not narrowing: Q3 2026 net loss of -$55.68 million (-62.8% net margin) compares with -$16.27 million a year earlier, and EPS deteriorated from -$0.28 to -$0.91. Operating income fell to -$61.90 million (-69.8% margin) from -$24.04 million, with SG&A ($47.8M) and R&D ($16.3M) scaling faster than gross profit.
- Cash burn requires external financing: TTM free cash flow is -$291.66 million (Q3 alone -$57.89 million) against negative FCF per share of -$0.95, and the -25.0x price-to-cash-flow ratio confirms operations consume rather than generate cash. The $553.6M cash balance was raised externally, not earned, leaving the company dependent on capital markets for Starlab and lunar development.
- Leverage spiked with Astrobotic deal: Debt-to-equity jumped to 1.22x from 0.018x in Q3'25, with total debt-to-capitalization at 73.4% and long-term debt-to-capitalization at 72.5%. Interest expense rose to $2.70 million in Q3 from $0.20 million a year earlier, adding a fixed cost burden just as losses deepen.
- Thin margins far below defense primes: Gross margin of 11.5% in Q3 2026 (and a negative -16.4% in Q1'26) sits well below the mid-to-high teens typical of defense primes and far under software-like space peers. With a -62.8% net margin, the 9.17x PS multiple prices growth but not profitability, leaving little room for execution error.
VOYG Technical Analysis
Voyager is in a structurally damaged but violently mean-reverting downtrend: the stock is up only 0.63% over the trailing year, yet sits just 53.6% of the way through its 52-week range (low of $20.33 set on 2026-11-05, high of $51.77 reached on 2026-05-28), having surrendered roughly 54% from that peak. The 180-day path shows a parabolic May advance from $30.82 to $51.77, a June–July collapse to $22.62, a second August spike back to $44.28, and a subsequent grind lower into the low $20s — a classic post-IPO boom-bust pattern with lower highs ($51.77 → $44.28 → $37.66) and lower lows. With a max drawdown of -60.73%, the stock is not near highs (where momentum would be extended) but also not a clean falling knife at the absolute low; it is a high-beta, headline-driven name in a confirmed intermediate downtrend.
Short-term momentum is deeply negative and decelerating relative to the longer-term trend: the stock is down 16.62% over one month and 42.70% over three months, versus a roughly flat 1-year return of +0.63%, a stark divergence signaling that the August catalyst-driven rally has fully unwound and then some. Relative strength confirms persistent underperformance — -11.63% vs. SPY over 1 month, -37.79% over 3 months, and -21.51% YTD — even as the S&P itself fell 4.91% over three months, meaning Voyager lost roughly eight times the market's decline. The one constructive datapoint is the most recent session: a +17.95% single-day surge from $20.33 to $23.98 on 2.26 million shares, a high-volume reversal candle off the 52-week low that hints at capitulation-style buying, though one session does not reverse a -42.70% quarterly slide.
Key technical levels are now clearly defined: support sits at the $20.33 52-week low (with secondary support near $22.62, the July trough), while resistance layers at $27.61–$30.25 (the October shelf) and then $37.66–$44.28 (the September/August highs). A decisive break below $20.33 would confirm a fresh leg lower and likely trigger momentum-fund liquidation, whereas reclaiming $30 would break the sequence of lower highs and suggest the November reversal has legs. Volatility is extreme — a -60.73% max drawdown and daily moves of 18% imply effective beta well above 2x the market even though a reported beta is not available — so position sizing should assume drawdown risk several times that of SPY, and stops must be wide enough to survive routine 10–15% swings.
Beta
—
—
Max Drawdown
-60.7%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+0.6%
Cumulative gain past year
| Period | VOYG Return | S&P 500 |
|---|---|---|
| 1m | -16.6% | -5.6% |
| 3m | -42.7% | -4.9% |
| 6m | -19.4% | -0.4% |
| 1y | +0.6% | +9.6% |
| ytd | -13.7% | +7.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VOYG Fundamental Analysis
Revenue is inflecting sharply upward: Q3 2026 revenue of $88.72 million grew 124.1% year-over-year versus $39.59 million in Q3 2025, and rose 68.2% sequentially from Q2's $52.75 million, capping a clear acceleration from $35.25M (Q1'26) → $52.75M (Q2'26) → $88.72M (Q3'26). The trajectory reflects both organic defense/space demand and inorganic contribution from the Astrobotic acquisition, with the $298 million NASA award providing multi-year backlog visibility; consensus estimates of roughly $3.06 billion in forward revenue (range $2.54B–$3.27B) imply management expects this step-change to persist. The investment case therefore hinges on whether this is durable contracted growth or acquisition-aided optics — the 124% YoY print is impressive, but the company must demonstrate organic follow-through as integration costs normalize.
Profitability remains deeply negative and is worsening in absolute terms even as gross margin stabilizes: Q3 2026 net income was -$55.68 million (net margin -62.8%) on gross profit of $10.23 million (11.5% gross margin), versus -$16.27 million in Q3 2025, while operating income fell to -$61.90 million (operating margin -69.8%) from -$24.04 million a year earlier. Gross margin has been erratic — -16.4% in Q1'26, 8.4% in Q2'26, 11.5% in Q3'26, and 15.4% in Q3'25 — reflecting contract mix and acquisition accounting, and at 11.5% it sits far below the mid-to-high teens typical of defense primes and well below software-like space peers. The loss trajectory is moving away from, not toward, breakeven: EPS deteriorated from -$0.28 (Q3'25) to -$0.91 (Q3'26), and SG&A plus R&D ($47.8M + $16.3M in Q3) are scaling faster than gross profit, meaning the path to profitability depends on operating leverage that has yet to materialize.
Balance-sheet risk is the central fundamental concern: free cash flow TTM is -$291.66 million (Q3 alone -$57.89 million), ROE is -27.3%, and debt-to-equity stands at 1.22x (up sharply from 0.018x in Q3'25 as the company took on debt for Astrobotic), with total debt-to-capitalization at 73.4% and long-term debt-to-capitalization at 72.5%. Liquidity is the offset — a 4.37x current ratio, 2.88x quick ratio, and $553.6 million in cash at quarter-end (up from $373.4M via $343.7M of net financing inflows) — but that cash was raised externally, not generated, and the company burned $29.7M in operations plus $28.2M in capex in Q3 alone. With a -25.0x price-to-cash-flow ratio and negative FCF per share of -$0.95, Voyager is entirely dependent on capital markets to fund Starlab and lunar development; the 1.22x leverage and persistent negative operating cash flow (-$0.49/share) mean any financing-window closure would be acutely painful.
Quarterly Revenue
$88715000.0B
2026-09
Revenue YoY Growth
+124.1%
YoY Comparison
Gross Margin
11.5%
Latest Quarter
Free Cash Flow
$-291660000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VOYG Overvalued?
Because trailing net income is negative (-$55.68 million in Q3, EPS -$0.91), the PE ratio is not meaningful — the trailing PE of -13.1x and forward PE of -0.34x are artifacts of losses, and EV/EBITDA of -16.8x is likewise unusable given negative EBITDA of -$47.5 million. I therefore lead with the price-to-sales ratio of 9.17x as the primary metric, supplemented by the 3.98x price-to-book; the 9.2x PS is the market's way of pricing a high-growth, pre-profit space/defense platform, and notably it has compressed dramatically from 20.8x at Q3'26 reporting and 43.9x a year ago as the share count and revenue base expanded faster than the market cap.
On a peer basis, a 9.17x PS multiple is a premium to the broader Aerospace & Defense industry (where primes typically trade at 1.5–2.5x sales) but sits at the low end of high-growth space and defense-tech comps, which have historically commanded 10–20x revenue; the stock's 3.98x P/B is rich versus industrial peers at 2–3x but reflects a capital-light book inflated by recent equity issuance. The premium to traditional defense is defensible only if Voyager sustains triple-digit growth and eventually converts its 11.5% gross margin into double-digit net margins — a gap the current -62.8% net margin makes glaring — while the discount to space-tech peers reflects the market's skepticism about cash burn and dilution. In short, the multiple prices in growth but not yet profitability, leaving little margin for execution error.
Historically, Voyager's PS has collapsed from 92.1x (Q1'25) and 49.3x (Q2'25) to 35.8x (Q2'26) and now 9.17x, while P/B has ranged from 22.0x at IPO-era pricing down to 3.98x today — placing the stock near the bottom of its own post-IPO valuation band. That compression is partly mechanical (revenue growth and share issuance) but also reflects genuine de-rating after the -60.73% drawdown; at 9.2x sales the market is no longer paying a euphoric multiple, which could represent a value opportunity if growth proves durable, or a warning that further multiple compression awaits if losses persist and another capital raise looms.
PE
-13.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
39.4x
Industry PE ~39.4x*
EV/EBITDA
-16.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are acute and quantifiable. TTM free cash flow of -$291.66 million (Q3 alone -$57.89 million, split between $29.7M of operating burn and $28.2M of capex) means the company consumes roughly $100 million per quarter, and the $553.6 million cash balance was built through $343.7 million of net financing inflows rather than operations. Debt-to-equity has risen to 1.22x from 0.018x a year earlier, with total debt-to-capitalization at 73.4%, and interest expense climbed to $2.70 million in Q3 from $0.20 million, so a closed financing window would be acutely painful. Revenue is concentrated in government programs — the $298 million NASA award and Astrobotic backlog — exposing results to contract timing, while gross margin has swung from -16.4% (Q1'26) to 11.5% (Q3'26) on contract mix, and SG&A plus R&D of $64.2 million in Q3 dwarf the $10.23 million gross profit, so profitability depends on operating leverage that has yet to appear.
Market and competitive risks center on valuation and sentiment. At 9.17x sales the stock trades at a premium to Aerospace & Defense primes at 1.5–2.5x, defensible only if triple-digit growth persists and 11.5% gross margin converts into double-digit net margins — a gap the -62.8% net margin makes glaring. The stock has lost 42.70% in three months against SPY's -4.91%, a -37.79% relative strength gap, and its -60.73% max drawdown with 18% single-day moves implies effective beta well above 2x, so sector rotation out of speculative space names hits it several times harder than the market. Competition is intensifying: Axiom Space raised $350 million for its private station, Intuitive Machines is positioned as the safer lunar contractor with profitability expected by 2027, and a benchmark space IPO could re-rate the whole group lower. Coverage is thin at five analysts on a $1.5 billion market cap, so a single downgrade — Morgan Stanley already moved to Underweight in July 2026 — can move the stock disproportionately.
The worst-case scenario is a financing-and-execution spiral: Starlab or lunar milestones slip, Q4 cash burn stays near $58 million, gross margin fails to hold double digits, and the company returns to equity markets at a depressed price, diluting holders just as Morgan Stanley's Underweight thesis gains traction. From the current $23.98, a retest of the $20.33 52-week low implies roughly -15%, and a decisive break below that level — with no analyst average target available to anchor support — would confirm a fresh leg lower toward the low-to-mid teens, a further -25% to -40% from here. The realistic downside range is therefore -15% to -40%, consistent with the -60.73% max drawdown already realized from the $51.77 May peak, and position sizing should assume drawdown risk several times that of SPY.
FAQ
Ranked by severity: first, financing/dilution risk — TTM free cash flow of -$291.66M and Q3 burn of $57.89M against $553.6M cash imply roughly 2–3 quarters of runway before another raise, and an offering at or below $20 would be the most damaging outcome. Second, profitability risk — Q3 net loss widened to -$55.68M from -$16.27M a year earlier, EPS deteriorated to -$0.91 from -$0.28, and gross margin has swung from -16.4% (Q1'26) to 11.5% (Q3'26), so operating leverage may never arrive. Third, balance-sheet and concentration risk — debt-to-equity jumped to 1.22x from 0.018x, interest expense rose to $2.70M from $0.20M, and revenue depends heavily on the $298M NASA award and Astrobotic backlog, making results sensitive to contract timing. Fourth, market and competitive risk — effective beta well above 2x (the stock fell 42.70% in three months versus SPY's -4.91%), Axiom Space's $350M raise and Intuitive Machines' 2027 profitability timeline intensify competition, and with only five analysts on a $1.5B market cap, a single downgrade can move the stock disproportionately.
The base case carries 55% probability with a $24–$31 range, assuming revenue growth decelerates to 40–70% as Astrobotic laps into the base, gross margin stabilizes in the low-to-mid teens, and cash burn of roughly $50–60M per quarter is funded by the $553.6M cash pile without a dilutive raise before mid-2027. The bull case (20% probability, $37.66–$44.28) requires gross margin above 15%, FCF burn below $40M, a new Starlab anchor tenant or NASA commercial-LEO award, and analyst target raises that make the $4.39 consensus forward EPS credible. The bear case (25% probability, $14–$20.33) assumes milestone slippage, Q4 burn near $58M, a margin relapse below 8%, and a depressed-price equity offering that breaks the $20.33 low. The base case is most likely because the stock is already chopping between the $22.62 July trough and the $30.25 October shelf, and the key assumption is that the existing cash balance defers the financing decision past the next two earnings reports.
Trailing and forward PE (-13.1x and -0.34x) and EV/EBITDA (-16.8x) are meaningless because the company is loss-making, so price-to-sales at 9.17x is the operative metric. That multiple is a steep premium to Aerospace & Defense primes at roughly 1.5–2.5x sales, but it sits at the very bottom of Voyager's own post-IPO band — down from 92.1x in Q1'25, 49.3x in Q2'25, and 43.9x a year ago — and at the low end of high-growth space-tech comps that have historically commanded 10–20x revenue. The 3.98x price-to-book is rich versus industrial peers at 2–3x, inflated by recent equity issuance. What the market is implying at 9.2x sales is that triple-digit growth persists and the 11.5% gross margin eventually converts into double-digit net margins; the -62.8% net margin shows how far that is from reality. Verdict: fairly valued to modestly undervalued versus its own history, but expensive versus defense peers — a growth option priced for execution, not a bargain.
Only for risk-tolerant investors who can tolerate a -60.73% drawdown, and only as a small satellite position. The risk/reward is genuinely two-sided: the PS multiple has compressed to 9.17x from 92.1x in Q1'25, revenue is growing 124.1% year-over-year, and roughly five of six covering analysts carry Buy/Overweight ratings, but there is no average price target in the data to quantify upside, and the company burned -$291.66M in TTM free cash flow against a $553.6M cash balance. The biggest downside risk is a dilutive equity raise at a depressed price, which would hit holders just as Morgan Stanley's Underweight thesis gains traction. A reasonable entry discipline is to wait for evidence — gross margin above 15% for two quarters with FCF burn below $30M, or a volume-backed reclaim of $30.25 — rather than buying the 17.95% bounce off the $20.33 low. For long-horizon investors comfortable with binary space-program outcomes, a starter position with strict sizing is defensible; for anyone needing near-term earnings visibility, it is not.
This is a long-term holding at its core, but one that requires short-term risk management. The business is early-stage — a June 2025 IPO, roughly 800 employees, a commercial space station (Starlab) still under development, and lunar capabilities only just acquired via Astrobotic — so the value-creating events (NASA contract execution, Starlab anchor tenants, operating leverage) play out over multiple years, not quarters. Against that, earnings visibility is very low: five analysts with a 39% spread between the $3.42 and $4.77 EPS estimates, 18% single-day moves, and a -60.73% max drawdown mean short-term trading is dominated by headlines and financing news rather than fundamentals. The token 1.8% dividend yield is immaterial to the thesis. A concrete minimum holding period of 18–24 months is appropriate, covering at least four to six quarterly reports and the next financing decision, with position sizing that assumes drawdown risk several times that of SPY and a willingness to add only on the evidence thresholds described above.